Using its own substance, Biosintez is planning to increase the production of a sodium nucleinate-based immunomodulator.

Sodium nucleinate is a natural immunomodulator1, one of the first preparations of nucleic acids derived from microorganisms. The drug has the activity of a polyclonal immunostimulant regulating migration of T-lymphocytes and the processes of T and B lymphocyte cooperation, enhances phagocytic activity of macrophages and production of non-specific defense factors. It accelerates the tissue regeneration processes and stimulates leukopoiesis2.

The drug is available in film-coated tablets of 250 mg and is indicated in the complex therapy of infectious diseases associated with the secondary immunodeficiency conditions: chronic nonspecific lung diseases, chronic recurrent viral and bacterial infections, secondary immunodeficiency states associated with aging, correction of leukopenia and agranulocytosis.2

1. Dotsenko E.A., Rozhdestvensky D.A., Yupatov G.I. Immunodeficiencies and some immunomodulating agents // Bulletin of the Voronezh State Medical University, - 2014, - VOL. 13, - No. 3 - P. 103-120.

2. Instruction leaflet for human use of medicinal product “Sodium nucleinate” Registration number: РN001284/01.